×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CRDF – cardiff oncology, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CRDF
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/15
04:28 pm
crdf
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer [Yahoo! Finance]
Medium
Report
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer [Yahoo! Finance]
4/15
04:10 pm
crdf
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
4/15
04:05 pm
crdf
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer
Medium
Report
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer
3/1
08:48 am
crdf
Cardiff Oncology Full Year 2024 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
Cardiff Oncology Full Year 2024 Earnings: Beats Expectations [Yahoo! Finance]
2/28
08:13 am
crdf
Cardiff Oncology, Inc. (NASDAQ: CRDF) had its price target raised by analysts at HC Wainwright from $13.00 to $17.00. They now have a "buy" rating on the stock.
High
Report
Cardiff Oncology, Inc. (NASDAQ: CRDF) had its price target raised by analysts at HC Wainwright from $13.00 to $17.00. They now have a "buy" rating on the stock.
2/27
05:49 pm
crdf
Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update [Yahoo! Finance]
2/27
04:05 pm
crdf
Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
Medium
Report
Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
2/24
04:05 pm
crdf
Cardiff Oncology to Present at Upcoming Investor Conferences
Medium
Report
Cardiff Oncology to Present at Upcoming Investor Conferences
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/13
04:06 pm
crdf
Form 4 Cardiff Oncology, Inc. For: Mar 11 Filed by: Kabbinavar Fairooz
Low
Report
Form 4 Cardiff Oncology, Inc. For: Mar 11 Filed by: Kabbinavar Fairooz
3/13
04:05 pm
crdf
Form 4 Cardiff Oncology, Inc. For: Mar 11 Filed by: Levine James E.
Low
Report
Form 4 Cardiff Oncology, Inc. For: Mar 11 Filed by: Levine James E.
3/13
04:03 pm
crdf
Form 4 Cardiff Oncology, Inc. For: Mar 11 Filed by: Smeal Tod
Low
Report
Form 4 Cardiff Oncology, Inc. For: Mar 11 Filed by: Smeal Tod
3/13
04:02 pm
crdf
Form 4 Cardiff Oncology, Inc. For: Mar 11 Filed by: Erlander Mark
Low
Report
Form 4 Cardiff Oncology, Inc. For: Mar 11 Filed by: Erlander Mark
2/27
04:15 pm
crdf
Form 8-K Cardiff Oncology, Inc. For: Feb 27
Medium
Report
Form 8-K Cardiff Oncology, Inc. For: Feb 27
2/27
04:12 pm
crdf
Form S-3 Cardiff Oncology, Inc.
Medium
Report
Form S-3 Cardiff Oncology, Inc.
2/27
04:01 pm
crdf
Form 10-K Cardiff Oncology, Inc. For: Dec 31
Medium
Report
Form 10-K Cardiff Oncology, Inc. For: Dec 31
2/12
02:48 pm
crdf
Form SCHEDULE 13G/A Cardiff Oncology, Inc. Filed by: PFIZER INC
Medium
Report
Form SCHEDULE 13G/A Cardiff Oncology, Inc. Filed by: PFIZER INC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: